Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTAX03 in Kellgren-Lawrence Grade 3-4 Knee Osteoarthritis
NCT05079035Phase 2Completed
- Sponsor
- BioTissue
- Start
- Dec 2021
- Primary completion
- Mar 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of TTAX03 in knee osteoarthritis (OA), sponsored by BioTissue. Started Dec 2021; status: completed.
02
Drugs
TTAX03
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05079035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05079035.